Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels
1996

Study of JM216 and Glutathione in Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Fl Raynaud, DE Odell, LR Kelland

Primary Institution: Cancer Research Campaign Centre for Cancer Therapeutics, The Institute of Cancer Research

Hypothesis

The study aims to characterize JM216 intracellular metabolism and evaluate the role of glutathione in drug detoxification.

Conclusion

Glutathione levels influence the metabolism of JM216, with lower levels leading to higher cytotoxicity.

Supporting Evidence

  • JM216 enters the cells and its biotransformation products depend on glutathione levels.
  • Depletion of glutathione increases the cytotoxicity of JM216 by approximately 2-fold.
  • Different metabolic profiles were observed in two ovarian carcinoma cell lines with varying glutathione levels.

Takeaway

This study looks at how a cancer drug called JM216 works inside cells and how a substance called glutathione affects its effectiveness.

Methodology

The study evaluated JM216's metabolism in two human ovarian carcinoma cell lines and assessed the effects of glutathione levels and BSO treatment on drug cytotoxicity.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication